Personalized Medical Care & Dedicated International Patient Concierge
CELLVIVE™ Anti-Aging
GLP-1 / GIP Weight Loss
GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) are naturally occurring incretin hormones that play a central role in appetite regulation, glucose metabolism, and energy balance.
Schedule a Consultation!
What Is GLP-1 & GIP Weight Loss Therapy?
GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) are naturally occurring incretin hormones that play a central role in appetite regulation, glucose metabolism, and energy balance. As part of the gut-brain hormonal axis, these peptides signal satiety to the brain, slow gastric emptying, and stimulate insulin secretion in a glucose-dependent manner.
In individuals with obesity or metabolic syndrome, the body's natural incretin response is often impaired or insufficient. GLP-1 and GIP receptor agonist therapies — administered as subcutaneous injections — work by mimicking and amplifying these natural hormonal signals. The result is reduced appetite, improved blood glucose regulation, and meaningful fat loss, particularly in visceral adipose tissue.
At ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC, GLP-1 and GIP therapy is administered within our CELLVIVE™ anti-aging framework. Consistent with the clinic's 4 Biological Axes of Aging model, metabolic dysfunction is recognized as a central driver of accelerated cellular aging. By restoring metabolic balance, GLP-1 and GIP therapy contributes not only to fat reduction but to a broader physiological reset — slowing the pace of inflammaging (inflammation-driven aging) and improving overall cellular health.
Our program pairs incretin therapy with slimming IV infusions designed to support metabolic activation, nutrient delivery, and energy optimization at the cellular level — creating a comprehensive, biologically coherent weight loss approach.
Who Is a Candidate for GLP-1 & GIP Weight Loss Therapy?
This program is appropriate for individuals who have struggled with weight management despite lifestyle modifications, or who present with underlying metabolic conditions that complicate traditional approaches. Our medical team conducts a thorough clinical evaluation prior to any treatment.
You may be a suitable candidate if you identify with several of the following:
Adults aged 30 and above who carry excess body weight, particularly in the abdominal or visceral region
Individuals with a body mass index (BMI) in the overweight or obese range, with or without a related comorbidity
Patients with insulin resistance, pre-diabetes, or type 2 diabetes seeking weight-related metabolic improvement
Those experiencing metabolic slowdown associated with hormonal shifts in midlife, including perimenopause and andropause
Individuals with chronic fatigue, low energy, or poor sleep quality linked to metabolic dysfunction
Patients who have undergone previous weight loss attempts without sustained success and are seeking a medically supervised alternative
Adults who wish to reduce cardiovascular risk factors associated with visceral fat accumulation
Individuals currently engaged in CELLVIVE™ anti-aging therapies who wish to extend their metabolic optimization as part of a comprehensive longevity program
This therapy may not be appropriate for individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pancreatitis, or certain gastrointestinal conditions. A complete medical consultation is required before initiating treatment.
Meet the Specialist
!
Dr. Hyo-jo Han
Specialist in Anesthesiology and Pain Medicine
Dr. Hyo-jo Han Specialist in Anesthesiology and Pain Medicine | Certified Advanced Pain Practitioner USMLE Step 1 & Step 2 — Passed
Dr. Han brings over 3,000 performed cervical and lumbar neuroplasty cases and more than 1,000 high-difficulty plasma disc decompression procedures to her clinical practice — a level of procedural depth that reflects an exceptional standard of precision medicine. Her extensive background in interventional pain management, cancer pain treatment, and chronic spinal disorders has informed a deeply systems-oriented approach to patient care.
Within the CELLVIVE™ anti-aging and metabolic medicine program, Dr. Han applies the same commitment to evidence-based, individualized care that defines her pain practice. She understands that obesity is not a behavioral failure but a complex, multifactorial condition with roots in hormonal physiology, neurological signaling, and chronic low-grade inflammation — the same biological systems she addresses across her clinical specialties.
At ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC, every patient's metabolic care plan is reviewed and supervised by Dr. Han, with adjustments made according to clinical response, individual tolerance, and evolving health goals. The clinic's philosophy is grounded in precision regenerative medicine: treating the biological system, not just the symptom.
Treatment Areas and Expected Improvements
GLP-1 and GIP therapy at ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC targets the following biological systems and clinical outcomes:
Visceral and Subcutaneous Fat Reduction: Incretin receptor agonists have demonstrated meaningful reductions in total body fat, with a particular affinity for visceral adipose tissue — the metabolically active fat surrounding internal organs that is most strongly associated with cardiovascular risk and systemic inflammation. Reductions in waist circumference and abdominal volume are among the most commonly observed outcomes. Individual results vary based on baseline metabolic health, adherence to the program, and complementary lifestyle factors.
Appetite Regulation and Satiety Signaling: By activating GLP-1 and GIP receptors in the hypothalamus and gastrointestinal tract, these therapies reset the hormonal signals governing hunger and fullness. Patients often report a natural reduction in food cravings, reduced compulsive eating behavior, and an improved relationship with food — outcomes driven by biology, not willpower. This effect supports sustainable caloric balance without extreme dietary restriction.
Blood Glucose and Insulin Sensitivity: Incretin therapies stimulate insulin secretion in response to elevated blood glucose while simultaneously suppressing glucagon — a hormone that raises blood sugar. Over time, this dual mechanism supports improved glycemic control and may reduce markers of insulin resistance. Patients with pre-diabetes or type 2 diabetes may see measurable improvements in fasting glucose and HbA1c with appropriate medical supervision.
Metabolic Rate and Energy Balance: In alignment with the Energy/Mitochondrial Axis of the clinic's 4 Biological Axes of Aging framework, our IV slimming therapy is paired with GLP-1/GIP injections to support cellular energy metabolism. These infusions are formulated to activate metabolic pathways and replenish the micronutrient environment in which fat mobilization occurs — supporting the body's capacity to use stored fat as an energy source more efficiently.
Chronic Inflammation Reduction: Visceral fat is a significant source of pro-inflammatory cytokines. As fat mass declines through this program, the associated inflammatory burden is reduced — directly supporting the Communication/Immune Axis of cellular aging. Reduced systemic inflammation is associated with improved immune function, lower risk of metabolic disease, and a measurable slowdown in the pace of biological aging.
Body Composition and Postural Balance: When combined with the clinic's CELLVIVE™ Growth Hormone (GH) therapy and CELLBURN IV program, GLP-1/GIP therapy can contribute to a shift in body composition — reducing fat mass while supporting lean muscle preservation. This is particularly relevant for patients in midlife, where muscle loss and fat gain frequently occur simultaneously as part of hormonal aging.
Treatment Process and Timeline
!
Step 1: Initial Medical Consultation
Your program begins with a comprehensive clinical evaluation with Dr. Han. Medical history, current medications, metabolic health indicators, and treatment goals are reviewed. This consultation determines candidacy and allows for a personalized protocol to be developed.
Step 2: Diagnostic Assessment
ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC uses data-driven diagnostics to inform your metabolic care plan. Baseline bloodwork and relevant metabolic markers are assessed. Consistent with the clinic's precision medicine approach, telomere length measurement and antioxidant balance testing may also be incorporated to evaluate your biological age and establish a cellular health baseline — allowing your anti-aging and metabolic programs to be coordinated as one integrated strategy.
Step 3: Program Design and Dosing Protocol
Based on your diagnostic data and clinical profile, Dr. Han designs a personalized GLP-1 and/or GIP dosing schedule. Dosing is titrated gradually to optimize efficacy and minimize gastrointestinal side effects, which are the most commonly reported adjustment-period symptoms. IV slimming therapy frequency is also determined at this stage.
Step 4: Injection Administration and IV Infusion
GLP-1 and GIP receptor agonist injections are administered subcutaneously, typically on a weekly schedule. Slimming IV infusions are scheduled in coordination with injection timing to support metabolic activation between doses. All administrations are conducted under clinical supervision at the clinic.
Step 5: Monitoring and Clinical Adjustment
Regular follow-up appointments allow Dr. Han's team to monitor clinical response, review bloodwork, assess tolerance, and adjust the protocol as needed. Weight, waist circumference, energy levels, and patient-reported outcomes are tracked systematically across the program.
Step 6: Long-Term Metabolic Maintenance
As treatment goals are approached, the clinical team works with each patient to develop a sustainable maintenance strategy. For patients enrolled in the broader CELLVIVE™ anti-aging program, metabolic therapy is integrated with cellular regeneration, hormone balancing, and longevity IV protocols to support long-term health optimization.
Results, Safety, and Longevity
GLP-1 and GIP receptor agonist therapies have been studied across large clinical populations, with published data supporting their role in meaningful, sustained weight reduction and cardiometabolic risk improvement when used as part of a supervised medical program. Results vary between individuals and are influenced by metabolic baseline, program adherence, duration of therapy, and complementary health practices.
Common side effects during dose initiation and titration include nausea, mild gastrointestinal discomfort, and reduced appetite — most of which diminish as the body adjusts. Serious adverse events are uncommon but may include pancreatitis or gallbladder-related conditions in susceptible individuals. A complete medical review prior to initiation is essential to identify contraindications.
Duration of effect is influenced by whether therapy is maintained or tapered. Our clinical team provides clear guidance on long-term management, recognizing that sustainable metabolic health requires ongoing attention to lifestyle, nutrition, hormonal balance, and cellular wellness — all of which are addressed within the clinic's integrated CELLVIVE™ framework.
ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC uses only clinically appropriate pharmacological agents, administered under physician supervision, with no improvised compounding or unvetted formulations. Patient safety, clinical transparency, and realistic outcome framing are non-negotiable standards of care.
Why Choose ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC for Metabolic Weight Loss?

ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC occupies a genuinely distinct clinical position: the convergence of advanced interventional pain medicine and precision anti-aging care under one roof. This integration means that metabolic health is never treated in isolation. When a patient presents for GLP-1 or GIP therapy, they are evaluated within the full context of their biological age, cellular health, hormonal environment, and inflammatory burden — not simply their body weight.
Dr. Han's background in anesthesiology and interventional pain medicine — encompassing more than 3,000 neuroplasty procedures and 1,000+ plasma disc decompression cases — reflects a standard of clinical precision that extends into every aspect of the clinic's care delivery. The same attention to anatomical detail, patient safety, and individualized protocol design that defines her pain practice informs how metabolic treatment plans are constructed and supervised.
The CELLVIVE™ framework, which underpins all anti-aging services at the clinic, treats weight management as one component of a broader biological restoration strategy. Consistent with the clinic's 4 Biological Axes of Aging — Damage Accumulation, Energy/Mitochondrial Function, Regeneration/Stem Cell Activity, and Communication/Immune Balance — GLP-1/GIP therapy is understood as a metabolic lever within a larger anti-aging system.
Key differentiators of the ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC's approach:
Physician-supervised, individualized dosing — no standardized protocols applied uniformly across patients; every plan is calibrated to the individual's clinical profile
Integration of GLP-1/GIP therapy within the CELLVIVE™ anti-aging framework — metabolic and cellular health are treated as interconnected, not separate concerns
Data-driven diagnostics — including telomere length measurement and antioxidant balance assessment — to establish biological age baseline and guide program design
Coordination with CELLBURN IV Therapy, Growth Hormone (GH) support, and longevity IV protocols for patients seeking a comprehensive metabolic and anti-aging outcome
Patient Experiences
Patient A: Midlife Metabolic Reset
A patient in their mid-40s presented with progressive abdominal weight gain over several years, persistent fatigue, elevated fasting glucose, and poor sleep quality — all symptoms consistent with early metabolic dysfunction. Following a comprehensive evaluation and baseline diagnostics, Dr. Han initiated a GLP-1 injection protocol titrated over eight weeks, paired with slimming IV infusions. At follow-up, the patient reported improved energy, reduced appetite, and measurable progress in abdominal circumference, alongside improved fasting glucose markers. The care plan was subsequently expanded to include CELLVIVE IV therapy as part of an ongoing cellular anti-aging program.
Patient B: Post-Plateau Weight Loss Support
A patient in their early 50s had maintained a consistent exercise routine and a health-conscious diet for years but had reached a plateau they could not overcome. Diagnostic review revealed insulin resistance and hormonal changes consistent with perimenopause, contributing to stubborn visceral fat retention. A personalized GIP-inclusive protocol was initiated alongside hormonal assessment and CELLVIVE™ growth hormone support. Over the following months, the patient experienced renewed progress in body composition, improved metabolic markers, and reported feeling more physically energized than she had in years.
Patient C: Integrated Anti-Aging and Weight Management
A patient already enrolled in CELLVIVE™ cellular anti-aging therapy requested the addition of GLP-1 and GIP therapy to address weight gain accumulated over the previous three years. Given their existing diagnostic data and established care relationship, the integration was seamless. The metabolic protocol was designed to complement ongoing CELLVIVE IV therapy and telomere-based aging assessments, with monthly reviews to assess both weight-related and cellular aging outcomes in parallel.
Take the First Step Toward Metabolic Renewal
Your body's weight challenges are not a personal failing — they are a biological signal that deserves a medical response.
At ST. MARY'S WELLNESS & PAIN MEDICINE CLINIC, Dr. Hyo-jo Han and the clinical team are ready to work with you to understand the underlying metabolic and hormonal factors driving your weight, design a personalized GLP-1 and GIP therapy protocol calibrated to your biology, and integrate metabolic care within a broader anti-aging strategy that supports your long-term health and vitality. This is precision medicine applied to weight management — evidence-informed, physician-supervised, and built around you.
Book Your Metabolic Consultation with Dr. Hyo-jo Han
Prefer to speak with the clinic first? Contact us directly to discuss your health goals and learn whether GLP-1 and GIP therapy is right for your situation. Our team is available to answer your questions and guide you through the consultation process.
Every patient is evaluated individually. Results are variable and dependent on clinical profile, adherence, and program duration. This page is for informational purposes only and does not constitute medical advice. A physician consultation is required before beginning any treatment.
Related Clinic Guides & Medical References
- Related Clinic Pages: CELLVIVE™ Anti-Aging · Dr. Hyo-jo Han (Pain Medicine Specialist) · 1:1 Consultation & Appointment Inquiry
- Clinical & Academic References: NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCBI PubMed Clinical Literature
Other Services
Explore additional treatments offered by our specialists.
Wound Healing & Tissue Recovery
Wound healing is a complex biological process that depends heavily on oxygen.
Learn More
RF Endermologie
RF Endermologie, or radiofrequency endermologie, is a non-invasive body treatment that fuses two clinically established modalities into a single, integrated therapy session.
Learn More
PRP Injection Therapy
Platelet-Rich Plasma (PRP) therapy is an autologous regenerative treatment — meaning it uses your own biological material to promote tissue healing.
Learn More